Form D · Biotechnology

Progentec Diagnostics, Inc.

Oklahoma City, OK · CIK 0001722842

Offering snapshot reported Nov 21, 2018 · SEC filing

Reported sold
$2.5M
Offering amount: $2.5M
Investors reported
7
Form D · investor count
Minimum accepted
$75K
Reported outside-investor minimum
First sale
Nov 9, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.25M$2.5MNov 21, 2017: $1,250,000.00Nov 21, 2017Nov 21, 2018: $2,500,000.00Nov 21, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,250,000 → $2,500,000
  • Reported investors5 → 7

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 21, 2018Amendment$2,500,000$1,250,000vs Nov 21, 20177SEC filing
Nov 21, 2017Initial$1,250,000No comparison5SEC filing

Offering details

Securities
Debt, Other
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-299302
Convertible Promissory Notes

Source: Form D, filed Nov 21, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mohan Purushothaman Director, Executive
Robert Saunders Director
Sanjiv Sharma Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
825 N.E. 13 Th Street Suite Mc 302.4, Omrf Building
Oklahoma City, OK, 73104